UBS Group AG - VISTAGEN THERAPEUTICS INC ownership

VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 53 filers reported holding VISTAGEN THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
UBS Group AG ownership history of VISTAGEN THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$24,659
+35.0%
197,268
+8.0%
0.00%
Q4 2022$18,264
-13.0%
182,646
+678.5%
0.00%
Q2 2022$21,000
+31.2%
23,461
+81.6%
0.00%
Q1 2022$16,000
-98.2%
12,922
-97.1%
0.00%
Q4 2021$871,000
+48.9%
446,788
+109.5%
0.00%
Q3 2021$585,000
+58400.0%
213,217
+85186.8%
0.00%
Q2 2021$1,000
-95.7%
250
-97.7%
0.00%
Q1 2021$23,000
-41.0%
10,799
-46.3%
0.00%
Q4 2020$39,000
+178.6%
20,100
-0.9%
0.00%
Q3 2020$14,000
-65.9%
20,276
-73.8%
0.00%
Q2 2020$41,000
+215.4%
77,521
+170.7%
0.00%
Q1 2020$13,000
-7.1%
28,637
+42.5%
0.00%
Q4 2019$14,000
-48.1%
20,100
-19.2%
0.00%
Q3 2019$27,000
+145.5%
24,868
+60.5%
0.00%
Q2 2019$11,000
-15.4%
15,496
+85.5%
0.00%
Q4 2018$13,000
-18.8%
8,354
-24.7%
0.00%
Q3 2018$16,000
+33.3%
11,092
-16.5%
0.00%
Q1 2018$12,00013,276
+6850.8%
0.00%
Q3 2017$0
-100.0%
191
-96.9%
0.00%
Q2 2017$11,000
+175.0%
6,087
+485.3%
0.00%
Q4 2016$4,000
+33.3%
1,040
+34.7%
0.00%
Q3 2016$3,0007720.00%
Other shareholders
VISTAGEN THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 11,728,033$36,943,00014.76%
VR Adviser, LLC 16,047,286$50,549,0006.13%
COMMODORE CAPITAL LP 3,331,315$10,494,0003.66%
Ghost Tree Capital, LLC 2,000,000$6,300,0001.73%
EPIQ PARTNERS, LLC 932,956$2,939,0001.47%
SPHERA FUNDS MANAGEMENT LTD. 4,080,673$12,854,0000.87%
SILVERARC CAPITAL MANAGEMENT, LLC 615,547$1,939,0000.86%
HighVista Strategies LLC 308,096$971,0000.69%
NEA Management Company, LLC 16,302,596$51,353,0000.67%
Nicholas Investment Partners, LP 2,753,880$8,675,0000.54%
View complete list of VISTAGEN THERAPEUTICS INC shareholders